- authorisedTherapeutic confirmatory (Phase III)
REVOLUTION; Randomized controlled trial comparing immediate versus extended release tacrolimus; reducing calcineurin inhibitor related toxicity in lung transplantation patients
This study looks at two different ways to give a medicine called tacrolimus to people who have had a lung transplant. The aim is to see if one way causes fewer side effects, especially problems with kidneys. It compares a standard capsule with a longer-acting tablet.
Netherlands - ongoing, recruitingTherapeutic use (Phase IV)
An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomised feasibility study. “Zero-Hep”
This study, called "Zero-Hep," is looking into how well a new way of doing lung transplants works. It's focused on a special type of life support called ECMO, but without using a blood-thinning medicine called heparin. Researchers want to see if this method causes fewer blood clots and other problems.
Austria